NCLEX-PN
NCLEX PN Practice Questions Questions
Extract:
Question 1 of 5
A client is admitted with the diagnosis of pulmonary embolism. While taking a history, the client tells the nurse he was admitted for the same thing twice before, the last time just 3 months ago. The nurse would anticipate the provider ordering
Correct Answer: B
Rationale: vena caval interruption. Clients with contraindications to Heparin, recurrent PE or those with complications related to the medical therapy may require vena caval interruption by the placement of a filter device in the inferior vena cava. A filter can be placed transvenously to trap clots before they travel to the pulmonary circulation.
Question 2 of 5
The home health nurse is caring for a 75-year-old client with dementia and suspects that the client may be experiencing elder mistreatment. Which of the following findings would be consistent with elder mistreatment? Select all that apply.
Correct Answer: B,C,D,E
Rationale: Pressure injuries, significant weight loss, broken eyeglasses, and expired medications suggest neglect or mistreatment. Disorientation is expected in dementia.
Question 3 of 5
During a situation of pain management, which statement is a priority to consider for the ethical guidelines of the nurse?
Correct Answer: A
Rationale: The client's self-report is the most important consideration. Pain is a complex phenomenon that is perceived differently by each individual. Pain is whatever the client says it is. The other statements are correct but not the most important considerations.
Question 4 of 5
The mother of a 1-week-old infant says to the nurse, 'When will that ugly black cord thing come off?' How should the nurse reply?
Correct Answer: B
Rationale: The umbilical cord typically detaches in 10 days to 3 weeks, providing accurate information. Other responses are irrelevant or incorrect.
Question 5 of 5
A client with leukemia has been receiving injections of Neulasta (pegfilgrastim). Which laboratory value reveals that the drug is producing the desired effect?
Correct Answer: B
Rationale: Neulasta (pegfilgrastim) stimulates the production of neutrophils, a type of white blood cell, to reduce the risk of infection in clients with neutropenia. A white blood cell count of 6,000/mm indicates an increase in white blood cells, showing the drug's desired effect. Hemoglobin relates to red blood cells, platelet count relates to clotting, and iron level is unrelated to Neulasta's action.